Advertisement

GI & Endoscopy

Baylor Research Institute, the research arm of Baylor Health Care System, and Eureka Genomics have partnered to study the causes of colorectal cancer for the advancement of the disease's prevention, management and treatment, according to a news release.

Advertisement

Avastin, in combination with chemotherapy, was expected to extend the lifespan of patients with cancer, including advanced colorectal tumors, by many years but is failing to live up to that expectation, according to a Bloomberg Businessweek news report.

Several recently published studies have demonstrated positive outcomes from the utilization of transoral incisionless fundoplication for the surgical treatment of gastroesophageal reflux disease.

There has been increased attention paid toward quality measures for colonoscopy, particularly adenoma detection rates and cecal intubation rates, some of which can also serve as predictors for interval colorectal cancer.

Advertisement